Shrinivas (Cheenu) Murti is Executive Director, Global Regulatory Affairs – CMC at Merck & Co., Kenilworth, NJ. He has a B.Pharm. from the University of Bombay, India, a Ph.D. in Pharmaceutical Sciences from the University of Missouri; and an MBA in General Management from Rutgers University.
Prior to Merck, Cheenu worked at Organon and Schering-Plough, including three years in the Netherlands. He joined Regulatory CMC in 2000 after positions of increasing responsibility in pre-formulation, product development, and technical operations. He has interacted with global health authorities on many topics of regulatory strategy and compliance, and has given invited presentations in the US, Europe and India.
Cheenu has been affiliated with several professional associations over his career and has served as a member of cross-industry working groups within AAPS, PhRMA, the IQ Consortium and ISPE, as also as Organon’s liaison with USP. He has developed and taught courses on CMC submissions and strategies in the US, The Netherlands, Spain and Turkey through Cobblestone since 2009, and lectured at several universities. He is a past President of the American Association of Indian Pharmaceutical Scientists (AAiPS).
